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Sterile single-use ultrafilters are used in dialysis for the preparation of the substitution fluid given to patients
undergoing dialysis treatments with high convective fluid removal. The retention of pyrogenic agents by the
ultrafilters is crucial to avoiding inflammatory responses. The performance of a new single-use ultrafilter
(NUF) with a positively charged flat sheet membrane of relatively small membrane area and large pore size
was compared to a reference ultrafilter (RUF) with a hollow fiber membrane. Filter performance was tested
with various pyrogen-contaminated dialysis fluids by direct pyrogen quantification and by measuring
inflammatory responses in cell-based bioassays. The NUF completely retained oligodeoxynucleotides
(ODN), whereas the RUF was fully permeable. Both filters tended to decrease biological activity of DNA in
filtered bacterial lysates. TheNUF reduced lipopolysaccharides (LPS) and LPS-induced biological activity by
100%, whereas the RUF produced filtrates with low but detectable levels of LPS in most cases.
Peptidoglycans (PGN) were fully retained both by the NUF and the RUF. The new ultrafilter retained
biologically activeODN,which has not yet been described for any other device used in dialysis, and it showed
better or equal retention of LPS and PGN even with a smaller membrane surface and larger pore size.
H
igh flux membranes for dialysis were introduced to reduce the morbidity and mortality of hemodialysis
patients by offering better removal than low flux membranes of large uremic retention solutes. Large
uremic solute removal with high flux membranes can be further improved in a hemodiafiltration (HDF)
setting. This setting allows high fluid flows and convective transport, providing the most effective removal of the
widest range of uremic retention solutes. Three controlled trials compared HDF therapy with low-flux hemo-
dialysis (CONTRAST1), with high-flux hemodialysis (TURKISH2) and with hemodialysis (ESHOL3) These
studies suggest a possible survival advantage only when high convection volumes can be delivered (. 20 l).
In an HDF setting, fluid removed from the patient needs to be substituted, and the quality of substitution fluid
is of utmost importance, particularly for those patients treated with high exchange volumes. Modern dialysis
machines prepare substitution fluid on-line, meaning that the fluid is continuously mixed by an on-line pre-
paration system consisting of water, concentrate supply and ultrafilters. Fluid prepared on-line is given to the
patient immediately after its preparation (Figure 1). The requirements for on-line preparation of sterile and non-
pyrogenic substitution fluid are described in the ISO11663 standard4.
Contamination of dialysis water and fluid by water-borne microorganisms gives rise to pyrogenic fragments of
microorganisms, which are a special matter of concern. Among the fragments are lipopolysaccharides, pepti-
doglycans, and short fragments of bacterial deoxynucleic acid (DNA). Each of these substances can be detected by
substance-specific assays or by bioassays with broader selectivity, and each of these substances is known for their
potential to cause an inflammatory response after transfer into the blood5.
On-line fluid preparation systems typically comprise a cascade of multiple ultrafilters to maintain the required
fluid quality6. One possible ultrafilter configuration includes a first ultrafilter installed within the dialysis machine
that purifies the incoming pretreated water; next, in the machine, this ultrafiltered water is mixed with acid and
bicarbonate concentrate delivered by a cartridge to generate dialysis fluid which is subsequently filtered through a
second ultrafilter installed in the dialysis machine. These machine-installed ultrafilters are disinfected after each
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fluid containing less than 0.1 colony forming units per ml and less
than 0.03 endotoxin units (EU)/ml can be achieved4. Sterile substi-
tution fluid for infusion (Sterility Assurance Level (SAL) 6 and ,
0.03 EU/ml) can be generated in a third filtration step by filtering
ultrapure dialysis fluid through a sterile single-use ultrafilter.
In the present study, a new sterile single-use ultrafilter was bench-
marked against a reference ultrafilter with respect to retention of
lipopolysaccharides, peptidoglycans and short bacterial DNA frag-
ments. For this purpose, target amounts of the relevant contami-
nants, based on the highest reported concentrations in dialysis
fluid7,8, were applied to represent the total contamination load in a
maximum volume of 50 l of dialysis fluid to be filtered for the pre-
paration of substitution fluid for one dialysis session. These levels of
contamination allowed the distinction between full retention and
(even) limited leakage.
Results
Pore sizes of ultrafilters. The average pore size of the reference
ultrafilter (RUF) was estimated to be 4.2 6 0.1 nm and therefore,
approximately 50 times smaller than the nominal average pore size of
0.2 mm of the new UF (NUF).
Retention of oligodeoxynucleotides. The challenge solution con-
taining a 19mer CG-rich oligodeoxynucleotide (ODN) (1000 ng/ml,
0.17 mM), and the corresponding filtrates of the NUF and the RUF
were quantitatively analyzed by the Quant-iT OliGreen Assay. The
NUF reducedODN in the challenge solution containing 9306 42 ng
ODN/ml to levels below the detection limit of 2 ng/ml, corre-
sponding to the background level of the buffer. In contrast, the
RUF did not retain ODN (filtrate, 841 6 44 ng/ml vs. challenge:
854 6 31 ng/ml) (Figure 2).
These data were confirmed by demonstrating the change of bio-
logical activity after filtration of the ODN-containing challenge solu-
tion by the reduction of interleukin-1-beta (IL-1b) mRNA
expression in peripheral bloodmononuclear cells (PBMC)measured
by quantitative reverse transcription polymerase chain reactions
(qRT-PCR). The challenge solution in the experiment with the
NUF induced a 1.47 6 0.24-fold IL-1b mRNA expression relative
to buffer, whereas after filtration, the IL-1b mRNA expression
dropped to 1.16 6 0.31-fold relative to buffer. In contrast, the chal-
lenge solution of the RUF induced 1.27 6 0.25-fold IL-1b mRNA
expression relative to buffer, and the IL-1b mRNA expression
induced by the filtrate of the RUF was 1.37 6 0.35-fold (Figure 3).
All these data indicate the full retention of bacterial oligonucleotides
by the NUF, whereas the RUF was completely permeable.
Retention of lipopolysaccharide. Ultrafilters were tested for their
retention of lipopolysaccharide (LPS). A challenge solution con-
taining LPS from the gram-negative bacterium, Pseudomonas
aeruginosa, with a response in the limulus amebocyte lysate (LAL)
test of 436 6 132 endotoxin units (EU)/ml was prepared. After
filtration with the NUF, the response in the LAL test of the filtrate
dropped below the detection limit of, 0.005 EU/ml. The filtrate of
the RUF still contained 6.26 6 0.94 EU/ml (1.99 6 0.37% was not
retained) (Figure 4).
Figure 1 | Flow charts of on-line dialysis fluid preparation. (a) The three
ultrafilters concept: reverse osmosis water is purified by a first ultrafilter.
In the machine, water is mixed with acid (A) and bicarbonate concentrate
(B) and processed through a second ultrafilter, resulting in ultrapure
dialysis fluid. Sterile substitution fluid for infusion is generated by a third
filtration step with a sterile single use ultrafilter. (b) The filtration set-up
for the benchmark study. The challenge solution is pumped across the
membrane to obtain the filtrate in a single-pass filtration step.
Figure 2 | Retention of ODN, assessed by measuring ODN
concentrations (ng/ml) by Quant-iT OliGreen assays. New ultrafilter
(NUF); Reference ultrafilter (RUF); Challenge solution (black bars);
Filtrates (white bar), LOD 5 2 ng/ml; *P , 0.001 versus buffer and
uP , 0.001 versus the corresponding challenge solution; n 5 3.
Figure 3 | Retention of ODN assessed by measuring IL-1b mRNA
expression levels induced in PBMCs (cytokine induction assay). The IL-
1b mRNA expression levels were measured by qRT-PCR. New ultrafilter
(NUF); Reference ultrafilter (RUF); Challenge solutions (black bars);
Filtrate (white bars); **P, 0.001; *P, 0.01 versus buffer and uP, 0.05
versus corresponding challenge solution; n 5 3.
www.nature.com/scientificreports
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These results were confirmed by the change in biological activity
after filtration of the challenge solution contaminated with LPS,
illustrated by the reduction or absence of cytokine (IL-1b) inducing
capacity (CIC) of the filtrates in the THP-1 cytokine induction assay
(CIA). In the filtrates obtained with the NUF, no CIC was detectable,
while 18.79 6 4.33% of the CIC remained in the RUF filtrates
(Figure 5).
The data from these experiments show that theNUF offers a better
retention performance for LPS than the RUF.
Retention of peptidoglycan. No peptidoglycan (PGN) could be
found with the silkworm larvae plasma (SLP) test in the filtrates of
either the NUF or the RUF. However, these quantitative SLP tests
were not reliable because an inhibition of the reaction was observed
with the ‘‘sample control’’ (buffer spiked with PGN) (, 1% of the
spike was retrieved), and the detected concentrations of the challenge
solution (6.1 6 2.6 ng/ml) were below 1% of the expected spiked
concentration (1000 ng/ml). For these reasons, the quantitative
analysis of PGN was omitted, and only the results of the bioassays
[THP-1 and pattern of recognition receptors (PRR)] were considered
in evaluating PGN retention. The THP-1 CIA revealed that after
filtration of the challenge solution contaminated with Bacillus
subtilis PGN (1000 ng/ml PGN resulted in 103.5 6 20.73 pg/ml of
IL-1b), the CIC of the NUF filtrates dropped to 11.23 6 1.18 pg/ml
of IL-1b, and the CIC of the RUF filtrates dropped to 11.30 6
2.09 pg/ml of IL-1b. These values were comparable to the baseline
levels (13.72 6 5.96 pg/ml IL-1b). In addition to B. subtilis PGN,
Staphylococcus aureus PGN (1000 ng/ml) was tested and resulted in
a response of .307 pg/ml IL-1b (out of range) in the challenge
solution. Again, no CIC was observed in the filtrates of either the
NUF or the RUF (Figure 6).
For confirmation of the findings of the THP-1 CIA, the challenge
solution with S. aureus PGN and the corresponding filtrates of the
NUF and the RUF were further analyzed with PRR bioassays. As
illustrated in Figure 7, the PGN challenge solution activated the cells
as reflected in the increased absorbance values. Activation via the
toll-like receptors TLR1/2, TLR2/6, TLR4/CD14 (selective for lipo-
polysaccharides) and TLR9 (selective for bacterial DNA) was
observed, pointing to the fact that the commercially obtained S.
aureus PGN was most likely not completely pure and contained
traces of LPS and bacterial DNA. However, this contaminated
PGN solution gave no detectable response in the LAL test.
The filtrate solutions obtained with the NUF and the RUF showed
reduced activation, down to background level, of all TLR-receptors
(Figure 7). These data confirm the complete retentive capacity for
biologically active PGN by both ultrafilters, consistent with the THP-
1 CIA described above.
Retention of bacterial lysates fromP. aeruginosa.The response to a
challenge solution containing 12.5 3 106 colony forming units
(CFU)/l of P. aeruginosa and to its filtrates was analyzed by the
Figure 4 | Retention of P. aeruginosa LPS assessed by determining LPS
concentrations (EU/ml) with the LAL test. New ultrafilter (NUF);
Reference ultrafilter (RUF); Challenge solutions (black bars); Filtrates
(white bar); LOD 5 0.005 EU/ml; **P , 0.001; *P , 0.01 versus buffer
and uuP, 0.001; uP, 0.01 versus corresponding challenge solution; n5 3.
Figure 5 | Retention of P. aeruginosa LPS assessed by estimating cytokine
(IL-1b pg/ml) induction capacity (CIC) in THP-1 cell cultures. The IL-1b
was measured in the supernatant by ELISA. New ultrafilter (NUF);
Reference ultrafilter (RUF); Challenge solution (black bars); Filtrates
(white bars); *P , 0.001 versus buffer and uP , 0.001 versus
corresponding challenge solution; n 5 3.
Figure 6 | Retention of PGN [B. subtilis and S. aureus] assessed by
estimating cytokine (IL-1b pg/ml) induction capacity (CIC) in THP-1 cell
cultures. The IL-1b was measured in the supernatant by ELISA. New
ultrafilter (NUF); Reference ultrafilter (RUF); Challenge solution (black
bars); Filtrates (white bars); *P, 0.001 versus buffer and uP, 0.001 versus
corresponding challenge solution; n 5 3.
Figure 7 | Retention of PGN (S. aureus) estimated by the pattern of
recognition receptors (PRR) bioassay (405 nm). New ultrafilter (NUF);
Reference ultrafilter (RUF); Challenge solution (black bars); Filtrates
(white bars); *P , 0.001 versus buffer and uP , 0.001 versus
corresponding challenge solution; n 5 3.
www.nature.com/scientificreports
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LAL test, the Quant-iT OliGreen assay and the THP-1 CIA and PRR
bioassays. The challenge solution induced a response in the LAL test
of 6.29 6 1.11 EU/ml, which dropped below the detection limit (,
0.005 EU/ml) after filtration with the NUF, whereas after filtration
with the RUF, the LPS levels, 0.039 6 0.012 EU/ml (0.60 6 0.12%
not retained), remained above the detection limit. ODN could not be
detected in the challenge solutions or the filtrates. The challenge
solutions containing gram-negative P. aeruginosa lysates, and the
corresponding filtrates of the NUF and the RUF were further
analyzed in the THP-1 CIA. The CIC of the challenge solution was
211 6 43 pg/ml of IL-1b, which dropped to baseline levels (8.58 6
0.50 pg/ml IL-1b) after filtration with either the NUF (12.20 6
2.81 pg/ml IL-1b) or the RUF (9.67 6 0.77 pg/ml IL-1b). Analysis
with the PRR assay demonstrated a significant and strong activation
of TLR4/CD14 (selective for lipopolysaccharides, p, 0.05 vs buffer).
In addition, there was activation of TLR1/2 and TLR2/6, selective for
peptidoglycans and other cell-wall fragments, and a trend toward
activation of TLR9, selective for DNA. The filtrates of both the
NUF and the RUF showed reduced activation of all TLR-receptors
down to background level, meaning reductions of 100% (Figure 8).
Discussion
Prototypes of a new single-use flat sheet membrane ultrafilter were
benchmarked against a reference ultrafilter with regard to the reten-
tion of known bacteria-derived pyrogens. In the past, systems for the
preparation of dialysis fluid were only tested for the retention of
intact microorganisms and intact LPS according to the ISO norm4.
However, other pro-inflammatory bacterial derivatives, including
PGN and bacterial DNA, definitely contaminate dialysis fluids7,8.
Thus, the evaluation methods applied in the present study were
extended beyond the classical definitions to encompass all contami-
nants with inflammatory potential.
One of the most interesting findings of this study was the lack of
retention of ODNs by the reference ultrafilter compared to the com-
plete retention by the new ultrafilter. The presence of bacterial ODN
in dialysate samples has been reported by Schindler et al., and con-
centrations of 0.3 mg/ml were detected. Those ODNs were shown to
have inflammatory capacity7. The latter observation was confirmed
by showing that bacterial DNA enhances cytokine production and
promotes the survival of inflammatory mononuclear cells from
chronic kidney disease patients9. More specifically, the inflammatory
response induced by the stimulation of the CD141CD161 pro-
inflammatory monocytic subpopulation10,11 by CpG DNA was
shown to result in endothelial cell apoptosis11. In addition, Bossola
et al. identified bacterial DNA in the blood of hemodialysis patients
and found that circulating bacterial DNA is associated with higher
levels of C-reactive protein and interleukin-6 in hemodialysis
patients12. Thus, especially when infusing purified dialysis fluid, pre-
vention of the transfer of ODNs into the blood should be a primary
aim to avoid pro-inflammatory effects contributing to cardiovascular
disease in hemodialysis patients.
The direct quantification of ODN revealed the clearest difference
between the NUF that reduced the ODN content of the challenge
solution down to undetectable levels in the filtrates and the RUF that
reduced ODN content only slightly. Beyond direct ODN quantita-
tion, bacterial DNA retention was also studied indirectly with the
PRR bioassay via the TLR9 response. The NUF retained ODN and
bacterial DNA in all tested cases, while the RUF was completely
permeable to ODN as revealed by the quantitative data (Figure 2).
But, theODNpermeability of the RUF could not be inferred from the
results of the PRR bioassays. It is of note that, to obtain a detectable
response, a minimal concentration of 5 mg/ml ODN is needed for
TLR9 in the PRR test system13, meaning that the quantitative
OliGreen assay is the more sensitive test and that ODN concentra-
tion below this value might remain undetected by the PRR test sys-
tem. Therefore, the biological activity of ODN was assessed with a
test system that was expected to be more sensitive than the PRR
bioassay, namely qRT-PCR analysis of IL-1b mRNA expression in
PBMC. The results of qRT-PCR analyses were in alignment with the
quantitative ODN measurements, which showed that the NUF
reduced ODN-induced cell activity down to baseline levels, whereas
the RUF had no effect.
Three retention mechanisms have been described in the literature:
size exclusion14, hydrophobic adsorption15, and electrostatic adsorp-
tion16. According to the latter retention mechanism, the positively
charged membrane of the NUF should be particularly efficient in
retaining negatively charged bacterial contaminants, including LPS,
PGN and bacterial DNA, in bicarbonate dialysis fluid. The retention
mechanism of ODN by the NUF is most likely based on an electro-
static charge interaction between the negatively charged ODNmole-
cules and the positively charged membrane. Retention by size
exclusion of ODN is unlikely because the nominal pore size of the
NUF is larger than themolecular dimensions of the tested ODN. The
electrostatic charge density of oligonucleotides is determined by the
phosphate-deoxyribose backbone of the ODN molecule, and there-
fore, it can be assumed that the retention characteristics do not
depend on a specific sequence of the nucleobases. The capacity to
completely retain biologically active ODN as observed with the NUF
has, to the best of our knowledge, not yet been described for any other
device applied in dialysis.
The new ultrafilter, NUF, also retained LPS more efficiently than
did the reference ultrafilter. No detectable amount of LPS could pass
the NUF in contrast to the RUF. Dialysis machines are able to gen-
erate ultrapure dialysis fluid with LPS levels lower than 0.03 EU/ml4
that passes the single-use ultrafilter to generate sterile substitution
fluid. Thus, additional LPS retentive capacity of the single-use final
ultrafilter might not be of relevance as long as the fluid systems are
properly operated and maintained. Nevertheless, this retentive capa-
city might be very useful even with minor contamination, especially
because the latter is rarely detected immediately, even with correct
and regular monitoring of dialysis water and fluid quality. Moreover,
controls of water quality at regular intervals as recommended17might
often be neglected. This risk becomes, by definition, greater as the
retentive capacity of a given ultrafilter becomes lower. It might seem
counterintuitive that the NUF with a larger nominal pore size and a
smaller membrane area retains LPS better than other ultrafilters with
largermembrane areas and smaller pore sizes, but retention based on
charge is very likely the principal mechanism at play in this context.
In view of the high contamination levels used in the present experi-
mental set-up, mimicking an LPS contamination of 10 EU/ml in the
dialysis fluid (ISO 11663:2009: , 0.5 EU/ml), which is highly
Figure 8 | Retention of bacterial lysates (P. aeruginosa) estimated by the
pattern of recognition receptor (PRR) bioassay (405 nm). New ultrafilter
(NUF); Reference ultrafilter (RUF); Challenge solution (black bars);
Filtrates (white bars); *P , 0.001 versus buffer and uP , 0.001 versus
corresponding challenge solution; n 5 3.
www.nature.com/scientificreports
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unlikely in reality, saturation of the new single use ultrafilter is not to
be expected during the course of a single dialysis session.
Biologically active peptidoglycans were equally and completely
retained by the NUF as well as by the RUF. PGN retention was
demonstrated by assessing the biological activity of PGN by the
THP-1 CIA and the PRR bioassay. Remarkably, the PRR bioassay
also suggested a co-contamination of biologically active LPS and
bacterial DNA in the S. aureus PGN solution, contaminants which
were no longer traceable in the filtrates of either the NUF or the RUF.
To assess the retention properties under conditions that reflect a
more complex mixture of pyrogens, lysates of P. aeruginosa were
tested. Here also, for both the evaluated ultrafilters (NUF and
RUF), no difference in the LPS and PGN retention capabilities was
observed. It is, however, of note that the degree of contamination in
the challenge solutions based on bacterial lysates was substantially
lower than in the test solutions containing purified contaminants.
Beyond the benchmarking aspect, our study raises the question
whether current recommendations for checking dialysis water and
fluid purity18 are sufficient to detect all important potential contami-
nants. This point is particularly relevant in case of on-line hemodia-
filtration compared with conventional hemodialysis because
potential contaminants can enter the blood stream not only by dif-
fusion but also by active infusion. One might object that the spiking
experiments, as performed here, do not conform to real-life circum-
stances. Pyrogenic substances used to challenge the ultrafilters were
selected according to three criteria: the relevance of the nature of the
contaminants, their concentrations in a dialysis setting and the avail-
ability of methods for quantification and evaluation of biological
activity5. Even more striking, for some ultrafilters and some sub-
stances, including the ODNs, virtually no removal was observed with
the currently used ultrafilters. Therefore, the discussion about water
purity and water purity standards is still relevant. Finally, the new
ultrafilter performs better with respect to the retention of LPS and
bacterial DNA, the latter being a novel finding that has not been
described for any other device.
Methods
Fluids.Dialysis fluid (‘‘buffer’’) was prepared with water purified by reverse osmosis,
acid concentrate (D242; 2–4 mmol/l) and bicarbonate concentrate (D200; 30–
40 mmol/l) to a final pH of 7.1–7.5 (Gambro Hospal, Kilchberg, Switzerland).
Ultrafilters. In the benchmark, prototype devices of a new single-use ultrafilter
(provided by Gambro Dialysatoren, Hechingen, Germany) were used. The NUF was
beta-sterilized and contained a flat-sheet membrane made of polyethersulfone with a
membrane area of 25 cm2, a thickness between 114 and 140 mm and a nominal pore
size of 0.2 mm. The membrane was modified so that a positive charge was created by
adding quaternary ammonium groups to the membrane surface. The housing was
made of polyethylene terephthalate glycol. For comparison, a commercially available
single-use ultrafilter (provided by Gambro Dialysatoren, Hechingen, Germany)
intended for ultrafiltration of fluids was used as the reference. The RUF was gamma-
sterilized and contained hollow fiber membranes based on polyethersulfone/
polyvinylpyrrolidone blends with inner diameters of approximately 200 mm, a
membrane thickness between 35 and 50 mm and a membrane area of 2000 cm2. The
pore size of the RUF was estimated by means of the Einstein-Stokes radius by the
filtration of dextran mixtures19. The housing was made of polycarbonate and
polyurethane was used for fiber potting.
Challenge solutions. The following purified contaminants were used:
lipopolysaccharide (500 EU/ml) from P. aeruginosa (Sigma, St. Louis, MO, USA),
peptidoglycan (1000 ng/ml) from B. subtilis (InvivoGen, San Diego, CA, USA), PGN
from S. aureus (InvivoGen, San Diego, CA, USA) and oligodeoxynucleotides (1 mg/
ml, 19mer, 59 TCGACTCTCGAGCGTTCTT) according to the sequences published
by Schindler et al.7,8 with a molecular weight of 5750 Da (TIB Molbiol, Berlin,
Germany). The ODN solution used for bioassays was filtered with the RUF
immediately after preparation, minimizing the risk of inducing a response to
potential contaminating pyrogens other than ODN.
Contaminant amounts in challenge solutions were chosen based on the highest
reported concentrations detected in dialysis fluid7,8 and were adjusted to represent the
total contamination load in a maximum volume of 50 l of dialysis fluid to be filtered
by ultrafilters for the preparation of substitution fluid during one dialysis session.
When meeting the ISO 11663:2009 standard4 for LPS allowing , 0.5 EU/ml in
dialysis fluid, amaximumLPS load in one dialysis session (50 l) equals 25,000 EU. To
mimic this in our experimental setting, filtering only 1 l, the dialysis fluid must
contain at least 25 EU/ml.
To create a more complex composition of contaminants, lysates directly derived
from bacterial cultures of P. aeruginosa (Gram negative, a major source of LPS;
BCCM/LMG, Gent, Belgium) were used as well. The cultures with a final concen-
tration of 12.5 3 106 CFU/l of P. aeruginosa were harvested, treated with heat
(20 min at 95uC) and ultrasound (1 min at 10 rpm) to induce bacterial disintegration
and then added to the dialysis fluid (buffer). For each filtration experiment, fresh
solutions were prepared.
Filtration set-up. The filtration for the benchmark was a single-pass filtration in
alignment with the respective clinicalmode of application (Figure 1). In the case of the
hollow-fiber membrane of the RUF, the filtration direction was from the lumen to the
outside. The filtration procedure comprised additional steps of priming the filters
with buffer to remove air and displacing the priming solution with the challenge
solution prior to the final single-pass filtration of 1 l challenge solution. A roller pump
was used to maintain a flow rate of 200 ml/min. Pyrogen concentrations were
measured in the initial challenge solution and in the total unfractionated filtrates.
Pyrogen concentrations weremeasured in the priming solution as a control to exclude
any contamination of the experimental set-up itself.
Three independent experimental repeats were conducted for the NUF and the RUF
and for each type of test solution.
Test systems for quantification. The Quant-iT OliGreen Assay (Invitrogen, NY,
USA), which is based on fluorescence enhancement by dye intercalation, was used for
the quantification of oligodeoxynucleotides. The assay was performed according to
manufacturer’s instructions, and fluorescence was determined using a FLUOstar
OPTIMA fluorescent plate reader with 480 nm excitation and 520 nm emission
wavelengths (BMG Labortech GmbH, Ortenberg, Germany). The detection limit was
2 ng/ml.
The Limulus Amebocyte Lysate test, a kinetic chromogenic assay (Kinetic-QCL
RH) (Lonza, Walkersville, MD, USA) with a detection limit of 0.005 EU/ml, was used
for quantification of intact LPS according to the manufacturer’s guidelines.
Escherichia coli 055:B5 was used to establish a standard curve.
The silkworm larvae plasma test (Wako Pure Chemical Industries, Osaka, Japan)
was used according to the manufacturer’s guidelines to estimate the concentration of
peptidoglycan. The limit of detection was 1 ng/ml.
THP-1 cytokine induction assay. The human monocytic cell line THP-1 (ATCC,
LGC Promochem, Middlesex, UK) was maintained as a continuous culture. Cell
cultures (1 3 106 cells/ml) were treated for 72 h with calcitriol (10 nM) (a gift from
Roche Pharmaceuticals, Basle, Switzerland) after which the medium was refreshed
followed by a 24 h rest period before the cells were used. The differentiated THP-1
cells were incubated in a 1:1 dilution (with a total volume of 700 ml) with the test
solutions (dialysis fluid or priming solution filtrate) in polystyrene, pyrogen-free
culture plates (Nunc, Roskilde, Denmark) for 24 h in a humidified atmosphere of 5%
CO2 in air at 37uC. After incubation, the culture suspensions were collected and
stored at 220uC. After a centrifugation step (5 min at 3000 rpm) IL-1b expression
was quantified in the culture supernatant using a sandwich ELISA kit (Quantikine
R&D Systems, Abingdon, UK).
PBMC qRT-PCR cytokine induction assay. For the qRT-PCR cytokine induction
assay PBMC were prepared from whole blood. Heparinized (15 IU/ml) whole blood
was collected under medical supervision from healthy donors after written, informed
consent that complied with approved local, ethical guidelines. PBMC were separated
by density gradient centrifugation in Hypaque-Ficoll (Sigma-Aldrich, Taufkirchen,
Germany). Cells were washed with saline and resuspended in RPMI 1640 cell culture
medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin (Life Technologies, Darmstadt, Germany). PBMCwere counted using a
KX-21Nblood cell counter (Sysmex, Norderstedt, Germany). PBMCwere diluted to a
concentration of 4 3 106 PBMC/ml in RPMI culture medium. Cell suspensions
(500 ml cell suspensions containing 2 3 106 PBMC) were incubated in 24 well plates
(BD Falcon, Heidelberg, Germany) in duplicates for 6 hours with 500 ml test solution
(buffer as the negative control, challenge solution, filtrates or positive control
solutions) in a humidified incubator that contained 5% CO2. After incubation, the
total RNA of the PBMC was isolated using the High Pure RNA Isolation Kit (Roche
Applied Science, Mannheim, Germany). Reverse transcription of the total RNA
(0.5 mg) was performed using anchored oligo (dT)18 primer and the Transcriptor
First Strand cDNA Synthesis Kit (Roche Applied Science). The cDNA (2 ml) was
analyzed in duplicate by quantitative real-time PCR with the LightCycler 1.5 system
(Roche Applied Science, Mannheim, Germany) using FastStart DNA MasterPLUS
SYBR Green I (Roche Applied Science, Mannheim Germany). Single product
amplification was checked by melting curve analysis supported by the LightCycler
software 3.5.3. The human IL-1b primers (sense, 59-AACAGGCTGCTCTGGGATT-
39, antisense, 59-TCATCCTCATTGCCACTGTAA-39) and GFAT primers (sense,
59-TGAACGGGAAGCTCACTGG-39, antisense, 59-
TCCACCACCCTGTTGCTGTA-39) amplified products of 122 and 307 bp. Each
PCR reaction was performed in a total volume of 20 ml (4 ml FastStart DNA
MasterPLUS and primers at a concentration of 250 nM each). The instrument
settings were as follows: denaturation at 95uC for 10 minutes followed by 40 cycles of
denaturation at 95uC for 10 seconds, annealing at 55–60uC for 10 seconds and
elongation at 72uC for 6–13 seconds (depending on the amplicon size). For absolute
www.nature.com/scientificreports
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quantification, serial dilutions of the desired gene fragments with known copy
number were performed and analyzed as external standards. Quantification was
performed by online monitoring for identification of the time at which the
logarithmic amplification phase was distinguishable from the background (crossing
point). The crossing point signals of the unknown samples were plotted against the
standard curve. The ‘‘Second derivative maximum method’’ supported by the
LightCycler software version 3.5.3 (Roche Applied Science, Mannheim, Germany)
was used for evaluation. The target gene (IL-1b) was corrected by using
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the reference gene.
Pattern of recognition receptors bioassay. Toll-like receptors are part of the pattern
of recognition receptor system, which specifically recognizes pyrogenic substances.
NIH3T3 cells (mouse fibroblasts) were stably transfected with the reporter gene,
secreted alkaline phosphatase (SEAP), under control of the nuclear factor (NF)kB
together with specific human TLRs and their co-receptors. The TLRs used in this
work included TLR1/2 and TLR2/6, which are selectively active in the presence of
lipoteichoic acid and peptidoglycans, TLR4/CD14, which is selectively active in the
presence of lipopolysaccharides, and TLR9, which is selectively active in the presence
of bacterial DNA13. TLR-activity was assessed by the level of alkaline phosphatase
activity induced. Alkaline phosphatase was assayed by the hydrolysis of the substrate
para-nitrophenyl phosphate to the product, para-nitrophenol (which is yellow at the
appropriate pH) and photometric quantification using a UV-VIS reader at 405 nm.
The software SoftMaxPro (Version 5.01) was used for data recording. All PRR
bioassays were conducted by contract with the Fraunhofer Institute for Interfacial
Engineering and Biotechnology, Stuttgart, Germany.
Statistics. Data are expressed as the mean 6 SD. Statistical analysis was performed
using an ANOVA with a Tukey’s mutiple comparison post-test using GraphPad
Prism 4.0. A P value of less than 0.05 was considered significant.
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